Antipsychotic Drug Use Since the FDA Black Box Warning: Survey of Nursing Home Policies

Journal of the American Medical Directors Association

Volumn 12, Issue 8, 2011, Pages 573-577

  Lester, Paula ^a   Kohen, Izchak ^b   Stefanacci, Richard G ^c   Feuerman, Martin ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b NSLIJ Health System   (United States)

^c UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Antipsychotics; Black box warning; Geriatrics; Nursing home; Policies

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ARTICLE; CONSULTATION; DEMENTIA; DRUG LABELING; DRUG USE; DRUG UTILIZATION; FAMILY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE FACILITY; HEALTH CARE POLICY; HUMAN; INFORMED CONSENT; NURSING HOME; NURSING HOME PATIENT; PATIENT CARE; SYMPTOM; UNITED STATES;

EID: 80053215338     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2010.04.005     Document Type: Article

References (23)

1. Evans D.A., Funkenstein H.H., Albert M.S., et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989, 262:2551-2556.
2. Madhusoodanan S., Shah P. Management of psychosis in patients with Alzheimer's disease: Focus on aripiprazole. Clin Interv Aging 2008, 3:491-501.
3. Magaziner J., German P., Zimmerman S.I., et al. The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: Diagnosis by expert panel. Epidemiology of Dementia in Nursing Homes Research Group. Gerontologist 2000, 40:663-672.
4. Special Care Units for People with Alzheimer's and Other Dementias: Consumer education, research, regulatory, and reimbursement issues, OTA-H-543 1992, US Congress Office of Technology Assessment, US Government Printing Office, Washington, DC.
5. Paulsen J.S., Salmon D.P., Thal L.J., et al. Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology 2000, 54:1965-1971.
6. Devanand D.P., Brockington C.D., Moody B.J., et al. Behavioral syndromes in Alzheimer's disease. Int Psychogeriatr 1992, 4:161-184.
7. Eustace A., Coen R., Walsh C., et al. A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease. Int J Geriatr Psychiatry 2002, 17:968-973.
8. Rabins P.V., Mace N.L., Lucas M.J. The impact of dementia on the family. JAMA 1982, 248(3):333-335.
9. Gilley D.W., Whalen M.E., Wilson R.S., Bennett D.A. Hallucinations and associated factors in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1991, 3:371-376.
10. Ray W.A., Federspiel C.F., Schaffner W. A study of antipsychotic drug use in nursing homes: Epidemiologic evidence suggesting misuse. Am J Public Health 1980, 70:485-491.
11. Omnibus Budget Reconciliation Act of 1987 (OBRA 87). Washington, DC: National Archives and Records Administration's (NARA) Office of the Federal Register (OFR), and the Government Printing Office (GPO). 1987.
12. Hughes C.M., Lapane K.L. Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: How successful have they been?. Drugs Aging 2005, 22:339-351.
13. Kamble P., Chen H., Sherer J., Aparasu R.R. Antipsychotic drug use among elderly nursing home residents in the United States. Am J Geriatr Pharmacother 2008, 6:187-197.
14. Liperoti R., Pedone C., Lapane K.L., et al. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. Arch Intern Med 2005, 165:2677-2682.
15. Briesacher B.A., Limcangco M.R., Simoni-Wastila L., et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 2005, 165:1280-1285.
16. Alexopoulos G.S., Streim J., Carpenter D., Docherty J.P. Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients. Using antipsychotics in older patients. J Clin Psychiatry 2004, 65:5-99.
17. Schneider L.S., Dagerman K.S., Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005, 294:1934-1943.
18. Deaths with antipsychotics in elderly patients with behavioral disturbances. FDA public health advisory Available at:, Accessed March 18, 2010. http://www.fda.org/Cder/drug/advisory/antipsychotics.htm.
19. Glick I.D., Murray S.R., Vasudevan P., et al. Treatment with atypical antipsychotics: New indications and new populations. J Psychiatr Res 2001, 35:187-191.
20. Daniel D.G. Antipsychotic treatment of psychosis and agitation in the elderly. J Clin Psychiatry 2000, 61:49-52.
21. Jeste D.V., Blazer D., Casey D., et al. ACNP White Paper: Update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology 2008, 33:957-970.
22. Kamble P., Chen H., Sherer J.T., Aparasu R.R. Use of antipsychotics among elderly nursing home residents with dementia in the US: An analysis of National Survey Data. Drugs Aging 2009, 26:483-492.
23. Kim H., Whall A.L. Factors associated with psychotropic drug usage among nursing home residents with dementia. Nurs Res 2006, 55:252-258.